Actos - Market Research and Reports
Actos, produced by Takeda Pharmaceuticals North America, Inc netted $2.5m in sales in 2009, the 9th highest in the world.
Actos is a type of thiazolidinediones, acting to increase sensitivity to Insulin. This sensitivity is lost in Type II Diabetes, the disease which Actos is prescribed for. Diabetes (Type II) is becoming increasingly common in the developed world, and may explain the high sales value of this drug.
Source; Adapted from BioPortfolio.com and Actos.com
BioPortfolio's Easy Ordering System
- Search for the report you need from our store
- Make online payment with our easy checkout process
- Receive PDF report via email
Easy Online Payment or Pro Forma Invoice
We accept the following credit cards...
or can supply a pro-forma invoice if required.